Future Medicine Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-13,367	-13,001	-10,502	-10,702
Depreciation & Amortization	447.28	428.34	322.39	290.92
Loss (Gain) From Sale of Assets	1.42	1.42	-	15.64
Asset Writedown & Restructuring Costs	-	-	-	30
Stock-Based Compensation	455.33	437.1	256.07	114.48
Provision & Write-off of Bad Debts	-	-	-0.15	0.15
Other Operating Activities	6,714	6,704	4,762	3,631
Change in Accounts Receivable	-	-	15	7
Change in Accounts Payable	-	-	-	-8.57
Change in Unearned Revenue	-	-	-51.46	21.47
Change in Other Net Operating Assets	-1,346	-1,117	985.36	36.43
Operating Cash Flow	-7,094	-6,547	-4,213	-6,563
Capital Expenditures	-110.72	-139.76	-86.9	-482.31
Sale (Purchase) of Intangibles	-100	-400	-231.01	-2.6
Investment in Securities	6,598	-53.5	-3,000	2,957
Other Investing Activities	-	-	-	33.75
Investing Cash Flow	6,388	-593.26	-3,318	2,506
Long-Term Debt Issued	-	-	-	7,040
Short-Term Debt Repaid	-	-	-	-202
Long-Term Debt Repaid	-	-148.6	-131.21	-130.74
Total Debt Repaid	-186.01	-148.6	-131.21	-332.74
Net Debt Issued (Repaid)	-186.01	-148.6	-131.21	6,707
Issuance of Common Stock	-	-	2,270	-
Other Financing Activities	0	0	-	-
Financing Cash Flow	-186.01	5,890	8,839	6,707
Foreign Exchange Rate Adjustments	36.07	-0.45	-0.11	-0.02
Net Cash Flow	-856.58	-1,251	1,307	2,650
Free Cash Flow	-7,205	-6,686	-4,300	-7,046
Free Cash Flow Margin	-720.50%	-668.64%	-	-
Free Cash Flow Per Share	-882.61	-885.51	-664.32	-1161.34
Cash Interest Paid	16.22	12.67	25	4.29
Cash Income Tax Paid	-	-	-	10.39
Levered Free Cash Flow	-	-19,496	4,540	-
Unlevered Free Cash Flow	-	-18,524	5,551	-
Change in Net Working Capital	-	14,471	-9,061	-

Source: S&P Capital IQ. Standard template. Financial Sources.